Advertisement
Advertisement
Promising Developments in PMV Pharmaceuticals’ Ovarian Cancer Treatment Drive Buy Rating
PremiumRatingsPromising Developments in PMV Pharmaceuticals’ Ovarian Cancer Treatment Drive Buy Rating
20d ago
PMV Pharmaceuticals announces updated rezatapopt monotherapy interim data
Premium
The Fly
PMV Pharmaceuticals announces updated rezatapopt monotherapy interim data
23d ago
Promising Phase 2 Trial Results and Strategic Plans Support Buy Rating for PMV Pharmaceuticals
Premium
Ratings
Promising Phase 2 Trial Results and Strategic Plans Support Buy Rating for PMV Pharmaceuticals
2M ago
PMV Pharmaceuticals Holds 2025 Annual Stockholder Meeting
PremiumCompany AnnouncementsPMV Pharmaceuticals Holds 2025 Annual Stockholder Meeting
5M ago
PMV Pharmaceuticals Reports Q1 2025 Financial Results
Premium
Company Announcements
PMV Pharmaceuticals Reports Q1 2025 Financial Results
6M ago
PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)
Premium
The Fly
PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)
6M ago
PMV Pharmaceuticals reports FY24 EPS ($1.14), consensus ($1.02)
PremiumThe FlyPMV Pharmaceuticals reports FY24 EPS ($1.14), consensus ($1.02)
9M ago
Pmv Pharmaceuticals, Inc. (PMVP) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Pmv Pharmaceuticals, Inc. (PMVP) Q4 Earnings Cheat Sheet
9M ago
PMV Pharmaceuticals files $200M mixed securities shelf
Premium
The Fly
PMV Pharmaceuticals files $200M mixed securities shelf
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100